Skip to main content
. 2023 Dec 12;17:3855–3866. doi: 10.2147/OPTH.S440575

Table 2.

Summary of Qualitative and Quantitative Assessment of MNV Morphology Secondary to Myopic Macular Degeneration (MMD) and Age-Related Macular Degeneration (AMD) Using SS-OCTA

MMD n=11 Eyes AMD n=33 Eyes p-value
MNV type 1 6/11 (55) 31/33 (94) 0.006
2 4/11 (36) 1/33 (3)
3 1/11 (9) 1/33 (3)
Location Subfoveal 8/11 (73) 24/33 (73) 1.000
Foveal sparing 3/11 (27) 9/33 (27)
MNV activitya Active 6/11 (55) 26/33 (79) 0.018
Scar 4/11 (36) -- --
Atrophic 1/11 (9) -- --
Silent -- 6/33 (18) --
Quiescent -- 1/33 (3) --
Shape Round 6/11 (55) 14/33 (42) 0.484
Irregular 5/11 (45) 19/33 (58)
Pattern Medusa 3/11 (27) 17/33 (52) 0.033
Sea-fan 2/11 (18) 11/33 (33)
Tree-in-bud 6/11 (55) 5/33 (15)
Well-defined margins 7/11 (64) 26/33 (79) 0.315
Presence of a core vessel 1/11 (9) 8/33 (24) 0.281
Presence of capillary fringe 4/11 (36) 18/33 (55) 0.296
Presence of perilesional dark halo 3/11 (27) 13/33 (39) 0.469
Presence of peripheral loops/arcades 8/11 (73) 28/33 (85) 0.367
Greatest linear dimension Length (mm) 1.41±0.90 2.44±1.38 0.009
Angle (degrees) −15.0±83.1 −34.2±61.3 0.491
Greatest vascular caliber (mm) 0.038±0.012 0.067±0.041 <0.001
MNV area (mm2) 1.38±1.53 4.73±4.86 0.001
Vessel density (%) 51.7±14.9 42.0±11.7 0.071
Branching Index 69.5±48.5 47.3±28.5 0.175
Total vessels length 12.5±12.6 36.0±33.8 0.002
Mean vessels length 6.39±10.16 4.40±3.67 0.537
Mean lacunarity 0.197±0.111 0.205±0.121 0.844

Notes: aMNV activity was classified as active, silent (treatment-free interval ≥ 3 months) or quiescent (or treatment-naïve) for eyes with AMD-MNV and in the active, scar or atrophic stages for MMD-MNV based on established criteria.10–12 The data is presented as mean ± standard deviation where applicable. The data in parentheses is presented as a percentage (%), and significant p-values (<0.05) are highlighted in bold.